Kenneth Evans

Dr Evans is President of Indoc Research, a not-for-profit company that helps medical researchers manage, share and analyze complex clinical, molecular and imaging data. Indoc-built platforms support a variety of research needs, including the Ontario Brain Institute’s large scale brain research programs (Brain-CODE: https://www.braincode.ca/ ). Dr Evans spent 15 years in the pharmaceutical and biotech industries, during which time he led the global clinical development of a number of innovative drugs. Dr. Evans has been instrumental in the start-up and implementation of several major collaborative (industry/academia) research initiatives, including projects aimed at improving clinical assessments (Parkinson’s, Huntington’s disease, Major Depressive Disorder) and at predicting drug/placebo response. Dr. Evans has also been involved in a number of translational biomarker research projects, including the use of PET imaging to predict drug response and various proteomic and genomic biomarker discovery and development programs in various diseases, including cancer and depression. Dr Evans holds two adjunct appointments: Associate Professor in the Department of Pathology and Molecular Medicine at Queen’s University, and Lecturer in the Department of Psychiatry at the University of Toronto.

Research Synopsis

Bioinformatics, Neuroscience, Genomics, Proteomics, Clinical scale development.